The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

MEDTR FINANCIAL STATEMENTS

Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi — balance sheet, income statement and cash flow trends

MEDTRMeditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi

🇹🇷 Turkey · IS · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
02 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue3.5 B ₺Gross Profit1.1 B ₺ · 31%Operating Income63.7 M ₺ · 2%Pre-tax Income-76.2 M ₺ · -2%Net Income to Owners4.6 M ₺ · 0%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue3.5 B ₺+22.0%
Gross Profit1.1 B ₺+7.8%
Operating Income63.7 M ₺-66.8%
EBITDA343.3 M ₺-18.1%
Net Income to Owners4.6 M ₺—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02 B4 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets4 B
  • Equity3.4 B ₺84%
  • Current Liabilities530 M ₺13%
  • Long-term Liabilities105.3 M ₺3%

Key Figures

YoY change
Total Assets4 B ₺+25.6%
Total Liabilities635.4 M ₺-5.3%
Total Equity3.4 B ₺+33.7%
Cash & ST Investments484.3 M ₺+13.4%
Total Debt27.9 M ₺-44.5%
Net Debt-444.7 M ₺—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0500 M1 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0500 M659.1 M ₺Operating272 M ₺Investing-327.3 M ₺Financing603.9 M ₺Net Change

Key Figures

YoY change
Operating Cash Flow659.1 M ₺-2.9%
Capital Expenditures-226.9 M ₺—
Free Cash Flow931.2 M ₺-2.4%
Dividends Paid-44.5 M ₺—

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on MEDTR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.